baber/WOPTO huggingface dataset:
Patent WO-2021252008-A1 (WO)
Title: Cloud-connected occupancy lights and status indication
Inventor: CHAKRABORTY ARINDAM
IPC: G08B21/00
Filed: 2020-11-10
Abstract: Methods and systems for providing an availability status associated with a facility. One system includes a visual indicator associated with a facility subsystem of the facility and a sensor configured to detect data associated with the facility subsystem. The system also includes a controller communicatively coupled to the visual indicator and the sensor. The controller is configured to receive a data from the sensor. The controller is also configured to determine a current availability status associated with the facility subsystem based on the data received from the sensor. The controller is also configured to control the visual indicator to indicate the current availability status associated with the facility subsystem.
Patent WO-2021108397-A1 (WO)
Inventor: NEISEN MATTHEW
IPC: F21S41/00
Filed: 2020-11-24
Abstract: A road working machine includes an operator's station that is adapted to be occupied by an operator of the road working machine. The road working machine also includes a controller and a safety light circuit that is operatively attached to the controller. The safety light circuit includes a plurality of downwardly directed safety lights that are located so as to provide lighted egress from the operator's station.
Patent WO-2021119199-A1 (WO)
Title: Inhibiteurs d'alpha-5 bêta-1
Inventor: SHEPPARD DEAN
IPC: A61K31/337
Filed: 2020-12-09
Abstract: L'invention concerne, entre autres    , des inhibiteurs d'alpha-5 bêta-1, des compositions pharmaceutiques comprenant des inhibiteurs d'alpha-5 bêta-1, des méthodes de traitement de maladies à l'aide d'inhibiteurs d'alpha-5 bêta-1, et des procédés de fabrication d'inhibiteurs d'alpha-5 bêta-1.
Patent WO-2021158288-A1 (WO)
Inventor: WANG GANG
IPC: H04L9/00
Filed: 2020-12-14
Abstract: Procédés, systèmes et appareil comprenant un procédé de détermination de mesures de réseau. Selon certains aspects, un procédé comprend la réception, par un premier serveur d'agrégation et à partir de chacun de multiples dispositifs clients, de données d'impression chiffrées. Un second serveur d'agrégation a reçu à partir de chacun d'au moins une partie des multiples dispositifs clients, des données de conversion qui comprennent, pour chaque conversion enregistrée par le dispositif client, des données de valeur de conversion chiffrées. Le premier serveur d'agrégation et le second serveur d'agrégation exécutent un processus de calcul à plusieurs parties pour déchiffrer les données d'impression chiffrées et les données de conversion chiffrées.
Patent WO-2021127414-A1 (WO)
Title: Use of fucosylation inhibitor for producing afucosylated antibody
Inventor: XU PING
IPC: C07K16/30
Filed: 2020-12-18
Abstract: The present invention provides inhibitors of fucosylation during protein expression from mammalian cells. The inhibitors are derived from rhamnose and act by inhibition of GDP-mannose 4,6-dehydratase (GMD). The invention further provides methods of making proteins with reduced level of fucosylation, such as antibodies and antibodies made by the methods of the present invention. Such hypofucosylated or nonfucosylated antibodies may find use, for example, in treatment of human disease in which is it therapeutically beneficial to direct antibody dependent cellular cytotoxicity (ADCC) mediated killing of cells expressing the antibody target on their surface, for example in depletion of Tregs in cancer patients using a hypofucosylated or nonfucosylated anti-CTLA-4 antibody.
Patent WO-2021146429-A1 (WO)
Title: Tilt indicator
Inventor: FONK ANTHONY
IPC: G08B21/18
Filed: 2021-01-14
Abstract: A tilt indicator includes a housing having a tilt detection assembly, switch circuitry, and a radio-frequency identification (RFID) module coupled to the switch circuitry. Responsive to the tilt detection assembly being subjected to a tilt event exceeding a threshold, the switch circuitry causes a change in a value output by the RFID module when activated.
Patent WO-2021154585-A1 (WO)
Title: Amino acid surfactants
Inventor: ASIRVATHAM EDWARD
IPC: C09K23/00
Filed: 2021-01-21
Abstract: The present disclosure provides derivatives of amino acids that have surface-active properties. The amino acid can be naturally-occurring or synthetic, or they may be obtained via a ring-opening reaction of a lactam, such as caprolactam. The amino acid may be functionalized to form a compound that is surface-active and have advantageous surfactant characteristics. The compounds of the present disclosure have low critical micelle concentrations (CMC) as well as superior ability to lower the surface tension of a liquid.
Patent WO-2021158687-A1 (WO)
Inventor: THOMAS RICHARD W
IPC: C09J189/06
Filed: 2021-03-08
Abstract: L'invention concerne un adhésif sensible à la pression biodégradable qui comprend, en % en parties : de 15 à 37 % d'eau, de 0,000 à 1,0 % d'antimousse, de 0,000 à 15,0 % de chlorure de sodium (NaCL), de 14 à 26 % de gélatine, de 6 à 18 % de glycérine/urée, de 0,000 à 0,700 % d'extrait de vanille, de 22 à 42 % de sucre/sirop de maïs, de 0,000 à 0,7 % de conservateur, pour un total de 100,00 %, et plus particulièrement, en % en parties : de 15 à 30 % d'eau, de 0,3 à 1,0 % d'antimousse, de 9 à 15,0 % de chlorure de sodium (NaCL), de 15 à 26 % de gélatine, de 6 à 16 % de glycérine, de 0,000 à 0,250 % d'extrait de vanille, de 24 à 40 % de sucre/sirop de maïs, de 0,2 à 0,6 % de conservateur, pour un total de 100,00 %.
Patent WO-2021163361-A1 (WO)
Title: Acoustic panels for a ceiling suspension system
Inventor: BIXEL DOUGLAS
IPC: E04B9/12
Filed: 2021-02-11
Abstract: A ceiling suspension system that includes a plurality of acoustic panels that are configured to be installed or attached into openings of a grid formed by main runners and cross runners of the ceiling suspension system. The acoustic panels include a plurality of main blades that extend in the same direction as the main runners and cross blades that extend in the same direction as the cross runners. Two or more of the main blades comprise a kerf in a first lateral edge of each main blade. The kerf comprises a first slot and a second slot that form a stepped configuration.
Patent WO-2021168060-A1 (WO)
Title: Methods for engineering amino acid ammonia lyase enzymes and enzymes thereby obtained
Inventor: NAIR NIKHIL
IPC: D06M16/00
Filed: 2021-02-18
Abstract: Disclosed are methods, systems, components, and compositions for engineering enzymes. Particularly disclosed are methods, systems, components, and compositions for engineering phenylalanine ammonia-lyase (PAL) enzymes and isolating variant PAL enzymes with enhanced enzymatic properties. The variant PAL enzymes disclosed herein or obtained by the methods disclosed herein may be utilized for treating diseases or disorders characterized by elevated blood levels of phenylalanine, such as phenylketonuria (PKU).
Patent WO-2021174166-A1 (WO)
Inventor: SCOTT STUART
IPC: E21B7/14
Filed: 2021-02-28
Abstract: System and method for conducting enhanced oil recovery by establishing a plurality of stacked, alternating slugs of gas and liquid travelling downhole into a subterranean well. The system can include a buffer tank including a liquid inlet through which liquid is received from a liquids source into the buffer tank, a gas inlet through which gas is received from a pressured gas source into the buffer tank, a gas outlet in fluid communication with gas reservoired in the buffer tank, and a liquid outlet in fluid communication with liquid reservoired in the buffer tank. The system can further include a pressure control configured to maintain a specified pressure in gas reservoired within the buffer tank and a fluid dispensing system in fluid communication with the gas and liquid outlets of the buffer tank.
Patent WO-2021183886-A1 (WO)
Title: Cycling of ablation devices
Inventor: KOLLMANN DANIEL
IPC: A61B18/18
Filed: 2021-03-12
Abstract: Various aspects of the present invention are directed towards apparatuses, systems, and methods that may include a tissue ablation system. The tissue ablation system may include a plurality of ablation devices, each ablation device being configured to provide ablation energy, at least one ablation generator configured to provide ablation power to at least one of the plurality of ablation devices, and a controller configured to cause each of the plurality of ablation devices to selectively receive ablation power and configured to cycle through activation of a plurality of ablation states.
Patent WO-2021216217-A1 (WO)
Inventor: KUMAR PEEYUSH
IPC: G06N3/04
Filed: 2021-03-15
Abstract: A computing system configured to execute a predictive program is provided. The predictive program, in a run-time phase, receives a current value for a remotely sourced forecast as run-time input into an artificial intelligence model. The artificial intelligence model has been trained on training data including a time series of locally sourced measurements for a parameter and a time series of remotely sourced forecast data for the parameter. The predictive program outputs a predicted forecast offset between the current value of a remotely sourced forecast and a future locally sourced measurement for the parameter. The predictive program outputs from the artificial intelligence model a predicted forecast offset based on the run-time input.
Patent WO-2021188545-A1 (WO)
Title: Downloadable software application for guiding a rapid test
Inventor: ROTHBERG JONATHAN
IPC: G01N33/543
Filed: 2021-03-16
Abstract: Described herein in one embodiment is software, which may be downloaded to a device, to guide a user through administration of a test. Test results may be uploaded, manually or automatically, to a device or communicated remotely through a network. In an embodiment, the test is a rapid test. In an embodiment, the rapid test detects presence of COVID-19. In an embodiment, the rapid test detects COVID-19 or influenza. In an embodiment, the rapid test detects influenza A or influenza B. In an embodiment, the rapid test detects a target nucleic acid. In an embodiment, the target nucleic acid represents one of a viral, bacterial, fungal, parasitic or protozoan pathogen. Each of the rapid tests may be self administrable.
Patent WO-2021188883-A1 (WO)
Title: Methods and compositions for the treatment of viral disease using granulocyte-macrophage colony-stimulating factor (gm-csf)
Inventor: POTTER HUNTINGTON
IPC: C07H21/04
Filed: 2021-03-19
Abstract: Embodiments herein relate to novel compositions and methods for treating viral infections and viral infection-related conditions. In some embodiments, compositions include, but are not limited to, at least one pro-inflammatory cytokine. In accordance with these embodiments, a proinflammatory cytokine can include Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) alone or in combination with other agents administered separately or together. In some embodiments, compositions including GM-CSF can be administered to a subject exposed to, suspected of having been exposed to, or having a viral infection. In other embodiments, the compositions treat, ameliorate or prevent a complication related to viral infection including, but not limited to, a central nervous system infection or condition and a lung infection or condition.
Patent WO-2021203003-A1 (WO)
Title: Mechanical valve for pressure control
Inventor: COBB ZACHARY ALLAN
IPC: F16K17/04
Filed: 2021-04-02
Abstract: A valve includes: a housing defining a chamber communicating with an inlet port and an exhaust port, a seat disposed in the housing between the inlet port and the exhaust port; an elastomeric or polymer sealing ring disposed in the seat; a valve element having a sealing surface that is a body of revolution, the valve element positioned in the housing such that it is moveable between a closed position in which the sealing surface is engaged with the sealing ring and an open position in which the sealing surface is disengaged from sealing ring; and at least one bypass channel defined in the chamber, arranged to communicate between the seat and the exhaust port when the valve element is in the open position.
Patent WO-2021262279-A1 (WO)
Inventor: MA HONGXU
IPC: G06Q10/04
Filed: 2021-04-06
Abstract: Implementations are described herein for predicting a future climate condition in an agricultural area. In various implementations, a teleconnection model may be applied to a dataset of remote climate conditions such as water surface temperatures to identify one or more of the most influential remote climate conditions on the future climate condition in the agricultural area. A trained machine learning model may be applied to the one or more most influential remote climate conditions and to historical climate data for the agricultural area to generate data indicative of the predicted future climate condition. Based on the data indicative of the predicted future climate condition, one or more output components may be caused to render output that conveys the predicted future climate condition.
Patent WO-2021225736-A1 (WO)
Title: Methods for determining detector gain in a flow cytometer
Inventor: BHABAN SHREYAS
IPC: G01N33/48
Filed: 2021-04-08
Abstract: Aspects of the present disclosure include methods for adjusting sensitivity of a photodiode in a light detection system. Methods according to certain embodiments include determining a background data signal from a photodetector at a plurality of detector gains, irradiating the photodetector with a light source at a plurality of different light intensities, generating data signals from the photodetector for the plurality of light intensities at each detector gain and adjusting the photodetector to the detector gain that corresponds to the lowest light irradiation intensity that generates a data signal resolvable from the background data signal. Systems (e.g., particle analyzers) having a light source and a light detection system that includes a photodetector for practicing the subject methods are also described. Non-transitory computer readable storage medium are also provided.
Patent WO-2021207634-A1 (WO)
Title: Biomarkers related to parkinson's disease and methods of using the same
Inventor: DOUD DEVIN FOREST REED
IPC: A61K31/351
Filed: 2021-04-09
Abstract: The present disclosure relates to the treatment of Parkinson's disease. The present disclosure provides, in some embodiments, methods of treating Parkinson's disease in a patient in need thereof. In some embodiments, the methods disclosed herein comprise administering a levodopa therapy based on a patient's biomarker profile. In some embodiments, the levodopa therapy comprises or lacks a tyrosine decarboxylase inhibitor. Therapeutic uses and compositions are also disclosed.
Patent WO-2021216415-A1 (WO)
Title: Compositions and methods for increasing sodium current in cardiac cells
Inventor: DUDLEY SAMUEL
IPC: C12Q1/68
Filed: 2021-04-19
Abstract: A method of increasing sodium current in a cardiac cell generally includes introducing into the cardiac cell an miR-488 inhibitor in an amount effective to decrease miR-488 suppression of  SCN 5A mRNA transcription, thereby increasing sodium current in the cardiac cell. A method of increasing translation of  SCN 5A mRNA in a cell generally includes introducing into the cell an miR-488 inhibitor in an amount effective to decrease miR-488 suppression of  SCN5 A mRNA transcription. A method of decreasing arrythmia in a cardiac cell generally includes introducing into the cardiac cell an miR-488 inhibitor in an amount effective to decrease miR-488 suppression of  SCN5A  mRNA transcription. A method of treating arrythmia in a patient having, or at risk of having, arrythmia generally includes administering to the patient an miR-488 inhibitor in an amount effective to decrease the likelihood or extent of arrythmia in the patient. In some embodiments of all methods, the miR-488 inhibitor can be an miR-488 antagomir or an miR-488 sponge.
Patent WO-2021243204-A1 (WO)
Title: Anti-cd200r1 antibodies and methods of use thereof
Inventor: CHEN YU
IPC: C07K16/28
Filed: 2021-05-28
Abstract: The present disclosure provides binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to human CD200R1 receptor protein (hu-CD200R1) and are capable of decreasing, inhibiting, and/or fully-blocking immune regulatory effects mediated by hu-CD200R1. The present disclosure also provides methods of using the antibodies (and compositions thereof) to treat diseases and conditions responsive to decreasing, inhibiting and/or blocking immune regulatory function or activity mediated by CD200 binding to CD200R1.
Patent WO-2021247597-A1 (WO)
Inventor: DU JUN
IPC: H04W8/00
Filed: 2021-06-01
Abstract: Techniques for performing Internet of Things (IoT) device identification are disclosed. Information associated with a network communication of an IoT device is received. A determination of whether the IoT device has been classified has been made. In response to determining that the IoT device has not been classified, a two-part classification process is performed, where a first portion includes an inline classification, and a second portion includes a subsequent verification of the inline classification. A result of the classification process is provided to a security appliance configured to apply a policy to the IoT device.
Patent WO-2021252593-A1 (WO)
Inventor: RAY BAPPADITYA
IPC: H04N19/70
Filed: 2021-06-09
Abstract: Un exemple de procédé de codage d'un nuage de points consiste à déterminer que des valeurs résiduelles pour toutes les composantes à l'exception d'une composante d'un attribut d'un point dans le nuage de points sont égales à zéro ; sur la base de la détermination selon laquelle les valeurs résiduelles pour toutes les composantes à l'exception de la composante de l'attribut sont égales à zéro, déterminer une valeur pour la composante qui est égale à une amplitude d'une valeur résiduelle de la composante de l'attribut moins un décalage ; coder la valeur de l'une des composantes ; et signaler la valeur codée dans un flux binaire.
Patent WO-2021262715-A1 (WO)
Inventor: HUANG CAI GU
IPC: A61P31/14
Filed: 2021-06-22
Abstract: The present invention relates to a liquid pharmaceutical formulation and a method for administering the pharmaceutical formulation by nebulizing the pharmaceutical formulation with an inhaler. The propellant-free pharmaceutical formulation comprises: (a) an active substance selected from the group consisting of alanine metabolite, nucleoside monophosphate, nucleoside triphosphate, and GS-441524; (b) a solvent; (c) a pharmacologically acceptable solubilizing agent; (d) a pharmacologically acceptable preservative; and (e) a pharmacologically acceptable stabilizer.
Patent WO-2022271157-A1 (WO)
Inventor: JABORI MONJI G
IPC: G06F8/656
Filed: 2021-06-22
Abstract: In some examples, a computing device, includes a first hardware device, a first firmware component coupled to the first hardware device, a second hardware device, a bus, and a basic input/output system (BIOS). In some examples, the BIOS is coupled to the first hardware device and to the second hardware device by the bus. In some examples, during a boot sequence, the BIOS is to set the second hardware device to a reset state. In some examples, the BIOS is to update instructions to the first firmware component via the bus while the second hardware device is in the reset state. In some examples, the BIOS is to lock the bus after the instructions are updated.
Patent WO-2022006227-A1 (WO)
Title: Systems and methods for location-based electronic fingerprint detection
Inventor: Peterson Derek
IPC: G08B21/12
Filed: 2021-06-30
Abstract: A notification system for location-based fingerprint detection includes a wireless device scanner, at least one sensor, and a remote server. The sensor is configured to sense parameters indicative of at least one of vaping, potential bullying, or smoking. The system further includes a processor, and a memory having stored thereon instructions which, when executed by the processor, cause the notification system to: detect an occurrence of vaping, potential bullying, or smoking based on the sensed parameters; receive, by the wireless device scanner, a wireless signal of a user device; determine a unique identifier of the user device based on the wireless signal; and transmit the determined unique identifier to the remote server.
Patent WO-2022006316-A1 (WO)
Inventor: TRINKLEIN NATHAN
IPC: C07K14/725
Filed: 2021-06-30
Abstract: L'invention concerne des anticorps à chaînes lourdes multispécifiques humains (par exemple, UniAbs TM ) se liant à BCMA, ainsi que des procédés de production de tels anticorps, des compositions, y compris des compositions pharmaceutiques, comprenant de tels anticorps, et leur utilisation pour traiter des troubles qui sont caractérisés par l'expression de BCMA.
Patent WO-2022011063-A1 (WO)
Title: System and method used to detect or differentiate tissue or an artifact
Inventor: VADALI VENKATA AKSHAY BHARGAV
IPC: A61B17/00
Filed: 2021-07-07
Abstract: A surgical system includes at least one light emitter and an array of light sensors disposed at the working end of the surgical instrument, individual light sensors in the array of light sensors adapted to generate a signal comprising a non-pulsatile component. The system also includes a controller coupled to the array of light sensors, the controller including an analyzer configured to determine a curve of the non-pulsatile components of the signals of each of the individual light sensors in the array of light sensors, to identify a plurality of regions of interest along the curve, to determine one or more regions of interest of the plurality of regions of interest to consider further based on one or more measures of closeness between the plurality of regions of interest, and to determine if one or more of the one or more regions of interest are more likely to be associated with a vessel or a tissue based on one or more parameters.
Patent WO-2022046491-A1 (WO)
Inventor: PHELPS LUKE
IPC: B60L8/00
Filed: 2021-08-18
Abstract: A rack for mounting solar panels on a vehicle includes a framework that couples to and support the solar panels. The framework has opposite first and second sides and a width therebetween. A first framework support attaches to the vehicle. The first framework support includes a first framework connector that couples to the first side of the framework. A second framework support attaches to the vehicle at a location spaced apart from the first framework support. The second framework support couples to the second side of the framework. The first framework connector defines a first plurality of different coupling locations for the first side of the framework to couple to in order to accommodate the width of the framework when the first and second framework supports are attached to the vehicle.
Patent WO-2022046921-A1 (WO)
Title: Shunts interauriculaires réglables, et systèmes et méthodes associés
Inventor: FAHEY BRIAN
IPC: A61F2/06
Filed: 2021-08-25
Abstract: La présente technologie concerne de manière générale des dispositifs médicaux implantables et des méthodes associées. Par exemple, un système conçu conformément à des modes de réalisation de la présente technologie peut comprendre un corps implantable dans un patient et conçu pour subir un changement de forme, le corps ayant un trajet conducteur avec une conductibilité variable dans des parties de celui-ci pour un chauffage sélectif et/ou préférentiel. Le corps peut être couplé à une source d'énergie qui peut délivrer de l'énergie au corps et/ou au trajet conducteur, afin de favoriser le changement de forme dans le corps.